Researchers at Stanford have developed a novel T cell engineering platform that leverages constitutively active interleukin-9 receptor (IL-9R) signaling to improve the efficacy and scalability of immunotherapies for solid tumors.
Stanford scientists have developed a new DNA-based technology that allows therapeutic genes to be maintained in human cells for extended periods without altering the cell's chromosomes.
Stanford researchers have developed the Large-scale Electrophysiology Amplification Platform (LEAP), a wireless, label-free optical system for monitoring the electrical activity of neurons and heart cells.
Researchers at Stanford have developed an innovative, non-invasive thermal treatment to recover the lost capacity of used lithium-ion batteries (LIBs), offering a scalable and cost-effective solution to the environmental challenges posed by battery waste.
Stanford researchers have developed a novel, multi-specific chimeric antigen receptor (CAR) T-cell therapy designed to overcome the key challenges of treating solid tumors, including tumor heterogeneity, immune evasion, and CAR T-cell exhaustion.
Stanford scientists have developed fully human CD19-targeted CAR T cells designed to overcome the limitations of current CAR T cell therapies, particularly in treating low CD19 density blood cancers.
Stanford researchers developed and patented a multiplexed immunohistochemistry method called multiplexed ion beam imaging (MIBI), which uses antibodies tagged with non-biological elemental isotopes (e.g. rare earth elements) and secondary ion mass spectroscopy.
Riffbot.ai is a web-based platform that leverages AI-powered, customizable chatbots to generate dynamic, personalized self-reflection experiences for learners while providing real-time insights to enhance engagement and improve learning outcomes at scale.
Stanford researchers have developed a novel, inverse-designed wavelength division multiplexer (WDM) that integrates high-performance Bragg gratings for use in optical communication systems.
Researchers at Stanford have developed an innovative molecular engineering strategy to enhance the stability and performance of polymer semiconductors (PSCs).
Stanford scientists have discovered that a specific protein signaling pathway can promote regenerative wound healing by suppressing fibrosis-related mechanosignaling.
Stanford researchers have developed a highly effective B7-H3 chimeric antigen receptor (CAR) for CAR-T cell therapy, designed to enhance binding and cytotoxicity against B7-H3 expressing solid tumors, offering a promising treatment for various cancers.
Stanford researchers in Prof. Michelle Monje's lab have developed a method for treating cognitive impairment (aka brain fog) caused by cancer immunotherapy.
Stanford scientists have developed an innovative Double-double (DD), thin-ply laminate technology that challenges traditional composite design rules to simultaneously reduce weight and cost.